Should Value Investors Buy Integer Holdings ( ITGR ) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
ITGR or SONVY: Which Is the Better Value Stock Right Now?
ITGR vs. SONVY: Which Stock Is the Better Value Option?
Integer Announces Conference Call to Discuss Third Quarter 2025 Results - Integer Holdings ( NYSE:ITGR )
PLANO, Texas, Sept. 25, 2025 ( GLOBE NEWSWIRE ) -- Integer Holdings Corporation ( NYSE: ITGR ) announced today that it will webcast its conference call discussing financial results and business highlights for the third quarter ended Sept. 26, 2025, on Thursday, Oct. 23, 2025, at 8 a.m. CT / 9 a.m.
Why Integer ( ITGR ) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
ITGR vs. SONVY: Which Stock Is the Better Value Option?
Investors interested in Medical - Instruments stocks are likely familiar with Integer ( ITGR Quick QuoteITGR - ) and SONOVA HOLDING ( SONVY Quick QuoteSONVY - ) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out.
Are Investors Undervaluing Integer Holdings ( ITGR ) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
3 Top Medical Instruments Stocks Defying Tariff Pressure With GenAI
Teleflex, Integer Holdings and Inogen are defying tariff and supply chain headwinds with genAI-driven momentum within the Medical Instruments industry.
Wall Street Analysts See a 31.74% Upside in Integer ( ITGR ) : Can the Stock Really Move This High?
The mean of analysts' price targets for Integer (ITGR) points to a 31.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
4 Value Stocks Every Investor Should Hold in Volatile Times
StoneCo, CVS, Integer Holdings and USANA emerge as attractive value stocks with low cash-flow ratios and solid growth outlooks.
ITGR or PEN: Which Is the Better Value Stock Right Now?
ITGR vs. PEN: Which Stock Is the Better Value Option?
Here's Why Integer ( ITGR ) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Integer to Present at 2025 Wells Fargo Healthcare Conference on Sept. 4
PLANO, Texas, Aug. 12, 2025 ( GLOBE NEWSWIRE ) -- Integer Holdings Corporation ( NYSE: ITGR ) , a leading medical device contract development and manufacturing organization, today announced participation in the 2025 Wells Fargo Healthcare Conference, to be held Sept. 3 - 5, in Boston.
4 Value Stocks to Shield Amid Labor Market and Trade Worries
CVS, ITGR, ASB and FNB emerge as value picks amid trade tensions and labor market concerns, thanks to strong cash flow metrics.
ITGR vs. PEN: Which Stock Is the Better Value Option?
Investors looking for stocks in the Medical - Instruments sector might want to consider either Integer ( ITGR Quick QuoteITGR - ) or Penumbra ( PEN Quick QuotePEN - ) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out.
Why Integer ( ITGR ) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Integer Holdings Q2 Earnings Miss Estimates, Revenues Up Y/Y
ITGR posts strong second-quarter revenue growth, but EPS misses estimate despite solid segment momentum.
Integer Posts 19 Percent EPS Gain in Q2
Integer ( NYSE:ITGR ) , a leading medical device contract manufacturer, released financial results for Q2 FY2025 on July 24, 2025. The headline news was GAAP revenue reaching $476 million, up 11.4% from Q2 2024 and beating analyst estimates by $11.63 million.
Integer ( ITGR ) Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.Thursday, July 24, 2025 at 9 a.m. ETPresident and Chief Executive Officer - Joe DziedzicContinue reading ...
Integer ( ITGR ) Q2 Earnings Lag Estimates
Integer (ITGR) delivered earnings and revenue surprises of -1.27% and +2.87%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
ECL Unveils ReadyDose Cleaning Program for Southeast Asian Restaurants
Ecolab rolls out ReadyDose, a tablet-based cleaning solution to help Southeast Asian restaurants cut waste and boost hygiene.
ISRG's Vessel Sealer Curved for da Vinci Systems Gets FDA Approval
Intuitive Surgical wins FDA nod for its Vessel Sealer Curved, boosting the da Vinci system's precision and multifunctional capabilities.
ITGR or PEN: Which Is the Better Value Stock Right Now?
ITGR vs. PEN: Which Stock Is the Better Value Option?
InspireMD Launches CGuard Prime Carotid Stent System in the U.S.
NSPR unveils FDA-approved CGuard Prime in the United States, targeting safer carotid procedures and stroke prevention.
Integer Appoints Michael Coyle to Board of Directors - Integer Holdings ( NYSE:ITGR )
~ New Director Brings Extensive Medical Device Industry Leadership and Technology Experience to Integer Board ~
Integer Appoints Michael Coyle to Board of Directors
~ New Director Brings Extensive Medical Device Industry Leadership and Technology Experience to Integer Board ...
Reasons to Add Fresenius Medical Stock to Your Portfolio Now
FMS continues to gain traction on the back of acquisitions & partnerships. A tough regulatory environment raises concerns.
AMN Stock Gains Post Latest Deals With symplr to Boost Operations
AMN Healthcare sells Smart Square to symplr for $75 million and forms a new technology partnership aimed at boosting scheduling efficiency.
Here's Why You Should Add PacBio Stock to Your Portfolio Now
PACB benefits from strong first-quarter results, product innovation, and cost cuts to offset macroeconomic concerns and drive 2025 growth.
Stereotaxis Reports Positive Initial Data From MAGiC Catheter Trial
STXS posts first peer-reviewed results for its MAGiC catheter, showing 94% efficacy and strong safety in arrhythmia treatment.
Intuitive Surgical's Fifth Generation da Vinci System Receives CE Mark
ISRG secures CE mark for its da Vinci 5 system, unlocking European access to its most advanced surgical platform yet.
Here's Why You Should Add HealthEquity Stock to Your Portfolio Now
HQY's sustained strength in HSAs raises optimism about the stock.
COO Stock Declines Despite Strong Core Growth Amid Fertility Woes
The Cooper Companies grows margins and premium products, but fertility softness, inventory cuts, and tariffs weigh on the near-term outlook.
SYK Boosts Foot & Ankle Portfolio With FDA-Cleared Total Ankle System
Stryker expands its Foot & Ankle portfolio with FDA-cleared InCompass, targeting streamlined total ankle replacement.
SNN Expands Orthopedic Portfolio With Advanced Tibia Nailing System
Smith + Nephew launches TRIGEN MAX, the only tibia nailing system with side-specific nails for precise, low-impact fracture repair.
Walgreens Q3 Earnings Top Estimates, Stock Up, Gross Margin Declines
WBA tops Q3 earnings and sales estimates and lifts shares, but the gross margin contracts, and guidance is withdrawn.
Reasons to Retain TransMedics Stock in Your Portfolio for Now
TMDX continues to witness growth on the back of its strength in OCS technology and the National OCS Program.
ITGR vs. PEN: Which Stock Is the Better Value Option?
Investors with an interest in Medical - Instruments stocks have likely encountered both Integer ( ITGR Quick QuoteITGR - ) and Penumbra ( PEN Quick QuotePEN - ) . But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look.
GEHC Stock Gains Post FDA's Nod for Vizamyl's Expanded Indications
GE HealthCare gains FDA nod to expand Vizamyl's use, unlocking new diagnostic and therapy-monitoring capabilities.
Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now
QDEL continues to witness growth on the back of its strong product portfolio.
BBNX Stock May Gain From Abbott Deal to Advance iLet Integration
Beta Bionics collaborates with Abbott to integrate its iLet system with a dual sensor, aiming to simplify and enhance diabetes care.
Here's Why MOH Shares Are Attracting Prudent Investors Now
Molina Healthcare draws investor interest with strong earnings growth, contract wins and premium revenue momentum despite rising costs.
Smith+Nephew Stock May Gain From Strategic Deal With Standard Health
SNN teams with Standard Health to launch the United Kingdom's first orthopedic ASC, aiming to boost surgical efficiency and drive growth.
Here's Why You Should Retain Ecolab Stock in Your Portfolio Now
ECL continues to gain from its robust product portfolio and strong segmental performance.
Encompass Health Plans a 50-Bed Unit to Better Serve North Las Vegas
EHC unveils plans for a 50-bed rehabilitation hospital in North Las Vegas, bringing improved health outcomes to the region's residents and further solidifying its Nevada footprint.
GE HealthCare Stock Slips Despite the Launch of bkActiv S Series
GEHC expands its bkPortfolio with the AI-powered bkActiv S Series to advance ultrasound-guided procedures.
Here's Why You Should Hold Accuray Stock in Your Portfolio for Now
ARAY continues to witness strength in its flagship, CyberKnife system, along with robust global performance.
VEEV Stock May Gain on the Launch of China Campaign Manager for Pharma
Veeva Systems launches China Campaign Manager to boost pharma engagement with localized, compliant CRM-driven solutions.
GEHC Stock Declines Despite Expansion in Precision Care Capabilities
GE HealthCare integrates proprietary algorithms into MIM Encore to advance digital imaging and workflow precision.
INBS Stock May Rise on SMARTOX Partnership Expanding Forensic Reach
Intelligent Bio Solutions collaborates with SMARTOX to expand U.S. forensic reach, boosting its drug test tech and eyeing FDA clearance for growth.
